Login for faster access to the best deals. Click here if you don't have an account.

SALES BUSINESS DEVELOPMENT

1 year ago   Financial Services   Chennai   82 views Reference: 31327
Job Details

Essential Duties and Responsibilities:

  • Sign-up new doctors onto the platform through self/ organization initiatives
  • Structured follow-ups to ensure Doctors are on boarded on the platform and using the product
  • Maintain large number of doctor relationships to ensure they stick to platform for long term, prevent doctor churns
  • Ensure seamless experience for doctors and patients on platform with timely resolution of all queries and concerns
  • Doctor backed view on the platform and digital engagement and suggest further improvements
  • Work with all stakeholders (product team, design team, content and marketing team etc.) to ensure best experience for doctors and patients with C2C platform
  • Ensure platform awareness among doctors and offer quick issue resolution
  • Managing doctor/ patient outreach campaigns, conducting demos to doctors and their staff virtually or physically as needed
  • Understanding doctor profiles (importance of doctor, tech savviness, patient demographics etc.) and the challenges and address then at product and process level to drive usage to ensure high recall
  • Co-ordinate with product team, do testing of new product launches
  • Prepare regular reports of progress and forecasts to internal and external stakeholders using key metrics;
  • Assist product team to understand customer problems, reproduce them and fix them

Apply Link- Apply Link mentioned in below

Company Description
Alkem set up its research and development facility for ANDA development at Taloja in 2003.[3] In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India.[4] In 2014 Clavam another drug from Alkem crossed 2,000 million mark in terms of domestic sales in India.
In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009.[3] Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.